Avantium N.V. and Will & Co B.V. signed a capacity reservation on 12 November 2026 for FDCA (furandicarboxylic acid) from future licensed production capacity, the companies announced.
The agreement builds on a February 2026 collaboration to develop FDCA in the CASE market. FDCA is a bio-based building block used in alkyd resins, surfactants and polyester polyols.
Under the deal, Will & Co expressed interest in reserving future FDCA capacity from plants operated by licensees of Avantium's YXY Technology. Avantium will facilitate discussions between Will & Co and prospective licensees.
Avantium produces FDCA at its Flagship Plant in Delfzijl, the Netherlands, and markets the PEF polymer under the releaf brand. The company is pursuing a licensing strategy to expand global FDCA capacity.
